|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,954.70 INR | +5.84% |
|
+4.30% | -0.66% |
| 05-12 | Pfizer Limited announces Annual dividend, payable on August 27, 2026 | CI |
| 05-12 | Pfizer Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2026 | CI |
| Capitalization | 227B 2.36B 2.03B 1.86B 1.77B 3.25B 3.3B 22.29B 8.62B 107B 8.86B 8.68B 375B | P/E ratio 2026 |
29.9x | P/E ratio 2027 * | 26.7x |
|---|---|---|---|---|---|
| Enterprise value | 227B 2.36B 2.03B 1.86B 1.77B 3.25B 3.3B 22.29B 8.62B 107B 8.86B 8.68B 375B | EV / Sales 2026 |
8.57x | EV / Sales 2027 * | 8.23x |
| Free-Float |
33.02% | Yield 2026 * |
1.08% | Yield 2027 * | 1.4% |
| 1 day | +5.84% | ||
| 1 week | +4.30% | ||
| Current month | +5.18% | ||
| 1 month | +2.12% | ||
| 3 months | -1.64% | ||
| 6 months | -2.35% | ||
| Current year | -0.66% |
| 1 week | 4,521 |  | 5,004.9 |
| 1 month | 4,521 | | 5,045 |
| Current year | 4,460 | | 5,257 |
| 1 year | 4,400 | | 5,993 |
| 3 years | 3,701 | | 6,451.15 |
| 5 years | 3,408 | | 6,451.15 |
| 10 years | 1,642 | | 6,451.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 02/04/2023 | |
Amit Agarwal
DFI | Director of Finance/CFO | - | 25/02/2024 |
Pankaj Gupta
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 06/12/1999 | |
| Director/Board Member | 66 | 13/02/2015 | |
Meena Ganesh
BRD | Director/Board Member | 62 | 07/03/2019 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.84% | +4.30% | +12.48% | +31.35% | 2.24B | |
| -0.00% | +3.07% | +40.44% | +131.32% | 898B | |
| -1.77% | +1.89% | +54.90% | +41.01% | 556B | |
| -0.18% | +3.79% | +18.57% | +42.98% | 372B | |
| +0.88% | +1.41% | +26.84% | +13.36% | 326B | |
| -0.79% | +2.39% | +36.02% | +13.51% | 287B | |
| -0.10% | +2.98% | +30.60% | +26.10% | 285B | |
| -1.79% | -0.82% | +51.60% | -4.92% | 280B | |
| +0.91% | +1.25% | -30.88% | -49.10% | 207B | |
| -2.22% | -0.84% | +24.41% | +40.08% | 181B | |
| Average | +0.70% | +2.02% | +26.50% | +28.57% | 339.47B | |
| Weighted average by Cap. | +0.14% | +2.63% | +33.59% | +49.53% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 25.26B 263M 226M 207M 198M 362M 368M 2.48B 961M 11.98B 988M 967M 41.8B | 27.54B 287M 247M 226M 215M 395M 402M 2.71B 1.05B 13.06B 1.08B 1.05B 45.56B |
| Net income | 7.25B 75.6M 65.01M 59.41M 56.72M 104M 106M 713M 276M 3.44B 284M 278M 12B | 8.32B 86.66M 74.52M 68.11M 65.02M 119M 121M 818M 316M 3.94B 325M 318M 13.76B |
| Net Debt | - | - |
Employees
1,598
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/05/26 | 4,954.70 ₹ | +5.84% | 96,077 |
| 14/05/26 | 4,681.10 ₹ | +1.47% | 20,294 |
| 13/05/26 | 4,613.50 ₹ | -2.38% | 33,132 |
| 12/05/26 | 4,725.90 ₹ | -3.07% | 23,483 |
| 11/05/26 | 4,875.40 ₹ | +1.17% | 23,896 |
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PFIZER Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition